Compared to age-matched healthy control, both parkin and AIMP2 mRNA levels were reduced in nasal fluid cells from MSA patients (94% reduction for parkin and 66% reduction for AIMP2, Supplementary Fig. S2). This evidence concerns the gene AIMP2 and multiple system atrophy.